BROWSE

ITEM VIEW & DOWNLOAD

PDK4 Deficiency Suppresses Hepatic Glucagon Signaling by Decreasing cAMP Levels

DC Field Value Language
dc.contributor.authorBo-Yoon Park-
dc.contributor.authorJae-Han Jeon-
dc.contributor.authorYounghoon Go-
dc.contributor.authorHye jin Ham-
dc.contributor.authorJeong-Eun Kim-
dc.contributor.authorEun Kyung Yoo-
dc.contributor.authorWoong Hee Kwon-
dc.contributor.authorNam-Ho Jeoung-
dc.contributor.authorYoung Hyun Jeon-
dc.contributor.authorSeung-Hoi Koo-
dc.contributor.authorByung Gyu, Kim-
dc.contributor.authorLing He-
dc.contributor.authorKeun-Gyu Park-
dc.contributor.authorRobert A. Harris-
dc.contributor.authorIn-Kyu Lee-
dc.date.available2019-01-03T05:31:57Z-
dc.date.created2018-10-15-
dc.date.issued2018-10-
dc.identifier.issn0012-1797-
dc.identifier.urihttps://pr.ibs.re.kr/handle/8788114/5142-
dc.description.abstractIn fasting or diabetes, gluconeogenic genes are transcriptionally activated by glucagon stimulation of the cAMP-protein kinase A (PKA)-CREB signaling pathway. Previous work showed pyruvate dehydrogenase kinase (PDK) inhibition in skeletal muscle increases pyruvate oxidation, which limits the availability of gluconeogenic substrates in the liver. However, this study found upregulation of hepatic PDK4 promoted glucagon-mediated expression of gluconeogenic genes, whereas knockdown or inhibition of hepatic PDK4 caused the opposite effect on gluconeogenic gene expression and decreased hepatic glucose production. Mechanistically, PDK4 deficiency decreased ATP levels, thus increasing phosphorylated AMPK (p-AMPK), which increased p-AMPK-sensitive phosphorylation of cyclic nucleotide phosphodiesterase 4B (p-PDE4B). This reduced cAMP levels and consequently p-CREB. Metabolic flux analysis showed that the reduction in ATP was a consequence of a diminished rate of fatty acid oxidation (FAO). However, overexpression of PDK4 increased FAO and increased ATP levels, which decreased p-AMPK and p-PDE4B and allowed greater accumulation of cAMP and p-CREB. The latter were abrogated by the FAO inhibitor etomoxir, suggesting a critical role for PDK4 in FAO stimulation and the regulation of cAMP levels. This finding strengthens the possibility of PDK4 as a target against diabetes. © 2018 by the American Diabetes Association-
dc.description.uri1-
dc.language영어-
dc.publisherAMER DIABETES ASSOC-
dc.titlePDK4 Deficiency Suppresses Hepatic Glucagon Signaling by Decreasing cAMP Levels-
dc.typeArticle-
dc.type.rimsART-
dc.identifier.wosid000445059100013-
dc.identifier.scopusid2-s2.0-85054779774-
dc.identifier.rimsid65721-
dc.contributor.affiliatedAuthorByung Gyu, Kim-
dc.identifier.doi10.2337/db17-1529-
dc.identifier.bibliographicCitationDIABETES, v.67, no.10, pp.2054 - 2068-
dc.citation.titleDIABETES-
dc.citation.volume67-
dc.citation.number10-
dc.citation.startPage2054-
dc.citation.endPage2068-
dc.embargo.liftdate9999-12-31-
dc.embargo.terms9999-12-31-
dc.description.journalClass1-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalWebOfScienceCategoryEndocrinology & Metabolism-
dc.subject.keywordPlusPYRUVATE-DEHYDROGENASE COMPLEX-
dc.subject.keywordPlusTRANSCRIPTION FACTOR-
dc.subject.keywordPlusINDUCED ACTIVATION-
dc.subject.keywordPlusLEYDIG-CELLS-
dc.subject.keywordPlusCYCLIC-AMP-
dc.subject.keywordPlusGLUCONEOGENESIS-
dc.subject.keywordPlusGLUCOSE-
dc.subject.keywordPlusMETABOLISM-
dc.subject.keywordPlusCREB-
dc.subject.keywordPlusPHOSPHORYLATION-
Appears in Collections:
Center for Genomic Integrity(유전체 항상성 연구단) > 1. Journal Papers (저널논문)
Files in This Item:
2018_DIABETES_PDK4 Deficiency Suppresses Hepatic Glucagon Signaling by Decreasing cAMP Levels.pdfDownload

qrcode

  • facebook

    twitter

  • Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse